Finally, we have observed that in the most primitive CML stem cells (CD34+38−90+ and Lin−CD34+38−), FOXO TFs are less inhibited despite the presence of BCR-ABL (Supporting Information Fig. S5). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.